# Hofseth Biocare

这家挪威生物技术公司在加工厂直接对新鲜（未冷冻）三文鱼头和骨进行专利连续酶水解，得到三种零废弃产品——纯化鱼油 OmeGo、可溶性蛋白水解物 ProGo 和关节用钙粉 CalGo。

Source: https://cn.bioecon.ru/companies/hofseth-biocare/
Updated: 2026-06-28

- 国家: Norway
- 代码: HBC.OL

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 通过定向增发募集 1.58亿挪威克朗，并以 500万美元出售 AecorBio Inc. 的股权（2025 年第四季度）；此前从 Aqua-Spark 募集 1000万欧元（2021 年），并获得 Symrise 提供的 500万欧元贷款（2025 年） | https://hofsethbiocare.com/news/hbc-accelerates-in-human-health-and-pet-nutrition-through-a-strategic-partnership-with-symrise-to-build-out-berk%C3%A5k-tripling-the-manufacturing-capacity-of-the-group, https://hofsethbiocare.com/uploads/images/HBC-Company-Presentation-2024.pdf, https://live.euronext.com/en/products/equities/company-news/2026-02-13-hofseth-biocare-asa-fourth-quarter-2025-financial-report, https://www.seafoodsource.com/news/processing-equipment/hofseth-biocare-building-second-hydrolysis-plant-to-extract-nutrients-from-atlantic-salmon |
| 产能 | 米德松德设施的原料年加工能力约为24,000公吨 | https://hofsethbiocare.com/uploads/images/HBC-Q3-2025-Financial-Report.pdf, https://ml-eu.globenewswire.com/Resource/Download/c15d3693-08ef-40d3-85d2-41d611b42259 |
| 认证 | Midsund实验室获ISO 17025标准认证;设施同时符合GLOBALG.A.P.水产养殖标准 | https://live.euronext.com/sites/default/files/company_press_releases/attachments_oslo/2025/04/11/643644_Hofseth%20BioCare%202024%20Annual%20report%20en.pdf |
| 监管批准 | 2025年在澳大利亚和韩国获得成分批准；在美国和欧盟已具备健康声明的监管框架 | https://live.euronext.com/en/products/equities/company-news/2026-02-13-hofseth-biocare-asa-fourth-quarter-2025-financial-report, https://ml-eu.globenewswire.com/Resource/Download/c15d3693-08ef-40d3-85d2-41d611b42259 |
| 生产基地 | 位于米德松德的现有设施；正在挪威贝尔科克建设第二处设施 | https://hofsethbiocare.com/news/hbc-accelerates-in-human-health-and-pet-nutrition-through-a-strategic-partnership-with-symrise-to-build-out-berk%C3%A5k-tripling-the-manufacturing-capacity-of-the-group, https://uk.finance.yahoo.com/news/hofseth-biocare-asa-commences-project-080000605.html, https://www.seafoodsource.com/news/processing-equipment/hofseth-biocare-building-second-hydrolysis-plant-to-extract-nutrients-from-atlantic-salmon |
| 员工人数 | 截至2024/2025年末员工人数为78至83人 | https://companybook.co/no/994464663/hofseth-biocare-asa, https://live.euronext.com/sites/default/files/company_press_releases/attachments_oslo/2025/04/11/643644_Hofseth%20BioCare%202024%20Annual%20report%20en.pdf, https://stockanalysis.com/quote/osl/HBC/revenue/ |
| 营收 | 2025全年为256.3 million挪威克朗 | https://live.euronext.com/en/products/equities/company-news/2026-02-13-hofseth-biocare-asa-fourth-quarter-2025-financial-report, https://ml-eu.globenewswire.com/Resource/Download/3a70cc6e-3505-4e2c-83b5-167aff541a9b |

独立来源: companybook.co, live.euronext.com, ml-eu.globenewswire.com, seafoodsource.com, stockanalysis.com, uk.finance.yahoo.com

## 技术

- [海洋肽与营养保健品](https://cn.bioecon.ru/technology/marine-peptides-nutraceuticals/)